首页> 外文期刊>Nephron >Effects of Adrenomedullln on the Glomerular AdrenomedulIin System in a Rat Model of Anti-Thy1 Glomerulonephritls
【24h】

Effects of Adrenomedullln on the Glomerular AdrenomedulIin System in a Rat Model of Anti-Thy1 Glomerulonephritls

机译:肾上腺髓质素对抗Thy1肾小球肾上腺皮质激素模型大鼠肾小球肾上腺髓质系统的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Adrenomedullin (ADM) has antiproliferative effects on glomerular mesangial cells. The study was performed to determine changes in glomerular gene expression of the ADM system by ADM treatment in anti-Thyl glomerulonephritis (GN). Methods: GN in rats was induced by injecting anti-Thy-1 antibody. To show the effect of ADM treatment, rats received ADM from day 3 to day 6 of GN. Supplemental rats were sacrificed on day 3, 7 and 14 of GN to show the expression pattern of adrenomedullin and its receptors. Glomeruli were prepared by sieving or laser-assisted microdissection. Expression of ADM, calcitonin receptor-like receptor (CLR), receptor activity-modifying proteins (RAMP) 1-3, CD34, Thy1 and nephrln was analyzed using real-time PCR. Results: During GN a reduction of CLR and RAMP 2 + 3 expressions was detected on days 3,7 and 14, while RAMP 1 rose. ADM mRNA decreased on days 3 and 7. Thy1 expression as a surrogate of mesangial cell number was downregulated during GN. A significant reduction of CD34 expression, as a surrogate for endothelial cell number, was detected on day 7. A tendency towards reduction of nephrin gene expression, as a surrogate for number of podocytes, was seen. The administration of ADM during GN did not change the expression on Thy1, CD34 or nephrln. The results were similar for microdissected and sieved glomeruli. In ADM-treated GN animals ADM gene expression rose compared to untreated GN animals on day 6. These effects were detected both in sieved and microdissected glomeruli. ADM administration did not change the expression of the receptors. Conclusion: The downregulatlon of adrenomedullin during GN at the gene level can be improved by ADM application.
机译:背景:肾上腺髓质素(ADM)对肾小球系膜细胞具有抗增殖作用。进行该研究以确定通过ADM治疗抗Thyl肾小球肾炎(GN)的ADM系统肾小球基因表达的变化。方法:注射抗Thy-1抗体诱导大鼠GN。为了显示ADM治疗的效果,大鼠从GN的第3天到第6天接受了ADM。在GN的第3、7和14天处死补充大鼠,以显示肾上腺髓质素及其受体的表达模式。肾小球是通过筛分或激光辅助显微解剖制备的。使用实时PCR分析ADM,降钙素受体样受体(CLR),受体活性修饰蛋白(RAMP)1-3,CD34,Thy1和nephrln的表达。结果:在GN期间,在第3、7和14天检测到CLR和RAMP 2 + 3表达下降,而RAMP 1上升。 ADM mRNA在第3天和第7天下降。在GN期间,由于系膜细胞数量的替代物,Thy1表达下调。在第7天检测到CD34表达显着降低,作为内皮细胞数量的替代物。观察到nephrin基因表达降低的趋势,作为足细胞数量的替代物。 GN期间ADM的给药未改变Thy1,CD34或nephrln的表达。显微解剖和筛分的肾小球的结果相似。与未处理的GN动物相比,在ADM处理的GN动物中,第6天的ADM基因表达增加。施用ADM不会改变受体的表达。结论:应用ADM可以改善GN在基因水平上肾上腺髓质素的下调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号